Guru Ownership Trend
Guru Analysis for Cytokinetics, Incorporated (CYTK)
Cytokinetics, Incorporated (CYTK), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $201.48 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $86.7 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 153.6%. Conversely, Chuck Royce reduced exposure by 18.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Cytokinetics, Incorporated (CYTK)
Major holders include Steven Cohen ($135.26 M), Ken Fisher ($63.36 M), Cliff Asness ($13.79 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 2.72 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $86.7 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited CYTK. The total reported sell value was $4.02 M.
Yes, 2 managers opened new positions in CYTK, and 2 increased their existing holdings. The total reported buy value was $90.73 M.
